CDC: Hep C Infections Among Pregnant Women Increasing

Share this content:
CDC: Hep C Infections Among Pregnant Women Increasing
CDC: Hep C Infections Among Pregnant Women Increasing

FRIDAY, May 12, 2017 (HealthDay News) -- The prevalence of hepatitis C (HCV) infection among pregnant women nearly doubled between 2009 and 2014, according to research published in the May 12 issue of the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.

The study reviewed birth records from 2009 to 2014. Researchers found wide variations in HCV prevalence at delivery, with rates from states reporting HCV on the birth certificate increasing 89 percent, from 1.8 to 3.4 per 1,000 live births. Increases were most notable in West Virginia and rural counties in Tennessee, areas strongly affected by the heroin and opioid epidemic, the CDC reported. Nationwide, 35 infants a day were exposed to HCV, on average.

In West Virginia, the investigators found that more than one in 50 newborns were exposed to HCV at the time of childbirth. In Tennessee, about one in 100 babies were exposed to the virus during delivery. Rates were three times as high in rural areas of the state compared to urban counties. Nationwide, the HCV rate among mothers-to-be was 3.4 per 1,000 live births in 2014. Regions hardest hit by opioid overdose deaths were also most likely to see increases in HCV infection.

The findings indicate that women of childbearing age need access to HCV testing and treatment, senior author Carolyn Wester, M.D., the medical director for HIV, sexually transmitted diseases, and viral hepatitis at the Tennessee Department of Health, said in a Vanderbilt University news release.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Cost-Effectiveness of PCSK9 Inhibitors Called Into Question

Cost-Effectiveness of PCSK9 Inhibitors Called Into Question

Researchers say price would have to be between $4,000 and $5,000 per year to be cost-effective

Vitamin B6, B12 Supplements May Up Risk of Lung Cancer in Men

Vitamin B6, B12 Supplements May Up Risk of ...

Increased odds only seemed to affect men or male smokers

Tablet Use Encourages Patients to Explore Diabetes Risk

Tablet Use Encourages Patients to Explore Diabetes Risk

Replacing magazines with tablets can help patients learn about diabetes risk, take preventive action

is free, fast, and customized just for you!

Already a member?

Sign In Now »